Spectrum Pharmaceuticals Faces Investor Scrutiny as Deadline Approaches for Class Action Lawsuit
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) finds itself at a critical juncture as investors are urged to act before the September 24, 2025 deadline in a securities class action lawsuit. Rosen Law Firm, a leading glob...
Sep 21, 2025
Announcement
Spectrum Pharmaceuticals
